Article Versions Notes

Klein FG, Granier C, Zhao Y, Pan Q, Tong Z, Gschwend JE, Holm PS, Nawroth R. Combination of Talazoparib and Palbociclib as a Potent Treatment Strategy in Bladder Cancer. Journal of Personalized Medicine. 2021; 11(5):340. https://doi.org/10.3390/jpm11050340

Klein, Florian G., Charlène Granier, Yuling Zhao, Qi Pan, Zhichao Tong, Jürgen E. Gschwend, Per Sonne Holm, and Roman Nawroth. 2021. "Combination of Talazoparib and Palbociclib as a Potent Treatment Strategy in Bladder Cancer" Journal of Personalized Medicine 11, no. 5: 340. https://doi.org/10.3390/jpm11050340

Klein, F. G., Granier, C., Zhao, Y., Pan, Q., Tong, Z., Gschwend, J. E., Holm, P. S., & Nawroth, R. (2021). Combination of Talazoparib and Palbociclib as a Potent Treatment Strategy in Bladder Cancer. Journal of Personalized Medicine, 11(5), 340. https://doi.org/10.3390/jpm11050340